Dr. Tuncay Delibasi's Channel

I'm Dr. Tuncay Delibasi and affiliated with UT Southwestern, Clinical Genetics. https://www.utsouthwestern.edu/sites/campus-news/covid-19/2021mar23.html

Dr. Tuncay Delibasi's old videos about Internal Medicine lessons

Endocrine Practice https://www.sciencedirect.com/science/article/abs/pii/S1530891X20420403 https://www.hindawi.com/journals/crie/2014/762745/ PDF: https://downloads.hindawi.com/journals/crie/2014/762745.pdf

Dr. Tuncay Delibasi explains Relationship of vaspin, apelin level, insulin resistance, and atherosclerosis in metabolic syndrome Source: https://www.caredash.com/doctors/tuncay-delibasi-vqjnv

More information about cell therapy can be found on https://issuu.com/tuncaydelibasi/docs/the_latest_procedure_of_stem_cell_therapy_for_type

Liraglutide 3·0 mg was shown to reduce bodyweight and improve glucose metabolism after the 56-week period of this trial, one of four trials in the SCALE programme. In the 3-year assessment of the SCALE Obesity and Prediabetes trial we aimed to evaluate the proportion of individuals with prediabetes who were diagnosed with type 2 diabetes.